The Patent Finder

Aralez Pharmaceuticals Trading Dac

Also on record
Records under this name other than patents Aralez Pharmaceuticals Trading Dac holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Aralez Pharmaceuticals Trading Dac

PatentTitleStatus Expires Confidence
US 7,541,471Synthesis of Himbacine Analogs
In force
 · High confidence
In forceHigh confidence
US 7,569,612Methods of Use of Fenofibric Acid
In force (reinstated)
 · Medium confidence
In force (reinstated)Medium confidence
US 7,741,373Methods of Use of Fenofibric Acid
In force
 · Medium confidence
In forceMedium confidence
US 7,741,374Methods of Use of Fenofibric Acid
In force
 · Medium confidence
In forceMedium confidence
US 7,915,247Methods of Use of Fenofibric Acid
In force
 · Medium confidence
In forceMedium confidence
US 7,605,275Exo- and Diastereo- Selective Syntheses of Himbacine Analogs
In force
 · High confidence
In forceHigh confidence
US 7,687,631Synthesis of DIETHYL{[5-(3-Fluorophenyl)-PYRIDINE-2YL]METHYL}PHOSPHONATE
In force
 · High confidence
In forceHigh confidence
US 7,772,276Exo-Selective Synthesis of Himbacine Analogs
Term ended
Term ended Oct 7, 2026 · High confidence
Term endedTerm ended Oct 7, 2026High confidence
US 7,989,653Exo- and Diastereo- Selective Syntheses of Himbacine Analogs
Term ended
Term ended Jan 25, 2026 · High confidence
Term endedTerm ended Jan 25, 2026High confidence
US 7,626,045Synthesis of Himbacine Analogs
Term ended
Term ended Jan 12, 2026 · High confidence
Term endedTerm ended Jan 12, 2026High confidence
10 of 25 records shown.
Pro members see all 25.
Pro members: see all 25 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited